Jefferies Group LLC Alnylam Pharmaceuticals, Inc. Call Options Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Sep 21, 2023	BUY	$138.54 - $232.0 $4.85 Million - $8.12 Million	35,000 Added 176.77%	54,800 $11 Million
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $4.85 Million - $8.12 Million	35,000 Added 176.77%	54,800 $11 Million
Q2 2022 Sep 21, 2023	BUY	$120.42 - $169.29 $1.78 Million - $2.51 Million	14,800 Added 296.0%	19,800 $2.89 Million
Q2 2022 Aug 15, 2022	BUY	$120.42 - $169.29 $1.78 Million - $2.51 Million	14,800 Added 296.0%	19,800 $2.89 Million
Q1 2021 Sep 21, 2023	SELL	$126.83 - $175.69 $1.19 Million - $1.65 Million	-9,400 Reduced 65.28%	5,000 $705,000

Q1 2021 May 14, 2021	SELL	$126.83 - $175.69 $1.19 Million - $1.65 Million	-9,400 Reduced 65.28%	5,000 $706,000
Q4 2020 Sep 21, 2023	SELL	$122.97 - $147.0 $4.97 Million - $5.94 Million	-40,400 Reduced 73.72%	14,400 $1.87 Million
Q4 2020 Feb 16, 2021	SELL	$122.97 - $147.0 $8.07 Million - $9.64 Million	-65,600 Reduced 82.0%	14,400 $1.87 Million
Q1 2020 May 15, 2020	BUY	$93.12 - $133.99 $6.05 Million - $8.71 Million	65,000 Added 433.33%	80,000 $8.71 Million
Q3 2019 Nov 13, 2019	BUY	$70.9 - $87.82 $1.06 Million - $1.32 Million	15,000 New	15,000 $1.21 Million
Q4 2018 Feb 14, 2019	SELL	$62.67 - $88.33 $2.24 Million - $3.15 Million	-35,700 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$87.52 - $122.67 $1.43 Million - $2 Million	16,300 Added 84.02%	35,700 $3.12 Million
Q2 2018 Aug 14, 2018	BUY	$88.31 - $107.8 $1.27 Million - $1.55 Million	14,400 Added 288.0%	19,400 $1.91 Million
Q1 2018 May 15, 2018	SELL	$115.92 - $148.54 $463,680 - $594,160	-4,000 Reduced 44.44%	5,000 $596,000
Q4 2017 Feb 14, 2018	SELL	$114.49 - $139.98 $21.2 Million - $26 Million	-185,500 Reduced 95.37%	9,000 $1.14 Million
Q3 2017 Nov 14, 2017	BUY	$72.53 - $118.27 $14.1 Million - $23 Million	194,500	194,500 $22.9 Million

Others Institutions Holding ALNY

# of Institutions

585

Shares Held

104M

Call Options Held

2.82M

Put Options Held

1.75M

Capital World Investors Los Angeles, CA

12.8M
Shares

$3.11 Billion
0.33% of portfolio
Vanguard Group Inc Valley Forge, PA

12M
Shares

$2.92 Billion
0.04% of portfolio
Black Rock Inc. New York, NY

9.03M
Shares

$2.2 Billion
0.03% of portfolio
Wellington Management Group LLP Boston, MA

7.21M
Shares

$1.75 Billion
0.2% of portfolio
Baillie Gifford & CO

6.62M
Shares

$1.61 Billion
0.78% of portfolio

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29.9B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account